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Abstract 
Hydrogels based on poly(methyl vinyl ether-co-maleic acid) and Tween 85 were prepared for 
hydrophobic drug delivery. The hydrogels were synthesized following a simple procedure carried out 
in solid state. The process did not require the use of any solvent and, as it is based on an 
esterification reaction, no toxic by-products were obtained. The resulting hydrogels contained 
Tween 85 inside the structure and due to the amphiphilic nature of this compound, hydrophobic 
domains within the hydrogel structure were formed. The obtained hydrogels showed good swelling 
capacities ranging from 100% to 600%. The esterification reaction that took place between 
poly(methyl vinyl ether-co-maleic acid) and Tween 85 was confirmed by infrared spectroscopy. 
Hydrogels were loaded with a hydrophobic drug model, Curcumin (CUR), showing that the hydrogels 
were able to retain up to 36 mg of CUR per g of hydrogel. Additionally, the synthesized hydrogels 
provided in vitro sustained CUR release over periods of up to 30 days. Finally, and due to the 
mucoadhesive nature of the prepared materials, one of the hydrogels was tested in vitro as an oral 
drug delivery system. For this purpose, the selected material was milled into microparticles (45-90 
µm diameter). The release of CUR from the microparticles was evaluated under simulated gastric 
and intestinal conditions. The microparticles were able to release their cargos in 7 hours. However, 
further work is required to optimize this system for oral drug delivery applications.  
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1. Introduction 
Hydrogels can be defined as three-dimensional networks of cross-linked polymers with a high 
capacity to absorb and retain water (Caló and Khutoryanskiy 2015; Hoare and Kohane 2008; Kopecek 
2009; Larrañeta, et al. 2018; Peppas, et al. 2000). The crosslinking between the polymer chains can 
be based on chemical bonds (chemical hydrogels) or non-covalent interactions (physical hydrogels) 
(Caló and Khutoryanskiy 2015; Hoare and Kohane 2008).  This type of materials can be prepared in a 
wide range of forms, such as micro/nano-particles, films, coatings or slabs among others (Hoare and 
Kohane 2008). Moreover, they can be produced using a wide range of polymers (Caló and 
Khutoryanskiy 2015; Hoare and Kohane 2008; Peppas, et al. 2000). As a result of this, hydrogels have 
been used extensively in clinical practice and experimental medicine for drug delivery, diagnostics or 
regenerative medicine (Caló and Khutoryanskiy 2015; Hoare and Kohane 2008; Peppas, et al. 2006). 
Physical hydrogels have been extensively used to deliver a wide variety of compounds such as 
macromolecules (Branco and Schneider 2008; Cappello, et al. 1998; Larrañeta E, et al. 2014; 
Larrañeta and Isasi 2014), while chemical hydrogels as drug delivery systems are limited to the 
delivery of small and hydrophilic drugs (Hoare and Kohane 2008). One of the main limitations of this 
type of materials is their ability to load and release hydrophobic drugs (Hoare and Kohane 2008; 
McKenzie, et al. 2015). Due to their hydrophilic nature they present poor homogeneity and drug 
loading when combined with hydrophobic compounds (Hoare and Kohane 2008; McKenzie, et al. 
2015). 
Hydrophobic drugs are playing an important role in current pharmaceutical treatment and it is 
estimated that about 40% of the marketed drugs and 60% of the compounds at research and 
development state present poor water solubility (Fahr and Liu 2007; Gu, et al. 2016). Consequently, 
hydrogels should be adapted to be able to deliver this type of compounds successfully. Several 
strategies have been developed to try to overcome this limitation. Two of the main approaches are 
the introduction of molecules capable of forming inclusion complexes (ie. cyclodextrins) inside the 
hydrogel networks and the incorporation of hydrophobic moieties in the hydrogel structure 
(Concheiro and Alvarez-Lorenzo 2013; Gu, et al. 2016; McKenzie, et al. 2015). 
Chemically-crosslinked hydrogels containing cyclodextrin moieties have been described extensively 
in the scientific literature (Concheiro and Alvarez-Lorenzo 2013; Crini and Morcellet 2002; Crini 
2003; García-Zubiri, et al. 2009; Machín, et al. 2013; Machín, et al. 2011). The incorporation of 
cyclodextrin molecules covalently attached to the hydrogel backbone increased the capacity of the 
material to retain hydrophobic drugs. These systems showed the ability not only to be loaded with 
hydrophobic drugs but to release them over short periods of time (Machín, et al. 2011). 
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A different strategy is to incorporate hydrophobic moieties to the hydrophilic polymers that forms 
the hydrogel (McKenzie, et al. 2015). This type of hydrogels are commonly physical-hydrogels 
(Larrañeta and Isasi 2012; McKenzie, et al. 2015). A simple way of obtaining physical gels is to attach 
a hydrophobic moiety to a hydrophilic polymer. Due to hydrophobic interactions, the system will 
aggregate forming a physical gel. This type of system includes hydrophobic regions inside the 
hydrogels. This regions can be used to load hydrophobic drugs effectively (McKenzie, et al. 2015). 
In the present work, the synthesis, characterization and evaluation of chemically crosslinked 
hydrogels containing hydrophobic moieties is presented. For this purpose, poly(methyl vinyl ether-
alt-maleic acid) was covalently crosslinked by using an ampiphilic molecule, Tween 85® (T85). The 
synthesis was developed in solid state using a thermal process that can be easily replicated and 
scaled up. Further, the developed hydrogels present potential as a system for hydrophobic drug 
delivery over prolonged periods of time. Curcumin (CUR) was used as a hydrophobic drug molecule 
model in order to evaluate the loading and release capacities of the synthesized hydrogels. The 
obtained results showed that T85 containing hydrogels have the potential to be used for prolonged 
delivery of hydrophobic drugs in applications such as drug eluting implants.  
 
2. Material and methods 
2.1. Materials 
Gantrez® S-97 (GAN) (acid form of methylvinylether and maleic anhydride copolymer) 
(Mw = 1.2 × 106 Da), was provided by Ashland (Tadworth, UK). T85 was obtained from Croda (Snaith, 
United Kingdom). CUR was purchased from Cambridge Bioscience (Cambridge, United Kingdom). 
 
2.2. Particle Size analysis of T85 solutions 
T85 water solutions were analysed using a Nano ZS Zetasizer and DTS software (Malvern 
Instruments, UK) at 25 °C. Each measurement (n = 3) had 10 sub measurements. 
 
2.3. Preparation of the hydrogels 
Aqueous solutions containing different ratios of T85 and GAN were prepared and 30g of these 
solutions were casted in 10x10 moulds. Solutions were allowed to dry over at least 48 hours. The 
resulting films were cut in pieces of 1x1 cm and subsequently placed inside an oven at 80°C for 24 
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hours. The hydrogels were named after the composition of the aqueous blends used to prepare the 
films (Table 1). GAN-based hydrogels were prepared by crosslinking the polymer with poly(ethylene 
glycol) (PEG) (Mw = 10,000) following the same protocol. These hydrogels were prepared using the 
previously optimized formulation described by Raj Singh et al (Raj Singh, et al. 2009).  
 
2.4. Hydrogel characterization 
Films (1.0 × 1.0 cm) were weighed as mo and then swollen in water for 24 hours at room 
temperature. At regular intervals, the films were removed, dried with filter paper to eliminate excess 
surface water and weighed as mt (hydrogels). The percentage swelling, was calculated, respectively, 
by using Equation 1. 
100  =Swelling % ×−
o
ot
m
mm
         (1) 
The same procedure was followed to study the swelling of hydrogels in pH 7 Phosphate Buffer 
Solution (PBS) and in HCl aqueous solution 0.12 M. 
The average molecular weight between crosslinks (Mc) was determined using equilibrium swelling 
theory. Mc can be determined by swelling studies according to the Flory and Rehner equation 
(Equation 3) (2) (Flory and Rehner 1943). All these calculations were carried out with the results 
obtained after swelling the hydrogels in water over a 24 hour timeframe. 
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The volume fraction of a polymer, ϕ, in the swollen state describes the amount of liquid that can be 
imbibed into a hydrogel and is described as a ratio of the polymer volume to the swollen gel volume 
(Equation 3). Vs is the molar volume of water (18 cm
3
/mol), χ is the Flory–Huggins polymer–solvent 
interaction parameter. This parameter (χ) reflects the thermodynamic interaction in hydrogels, 
which in turn indicates the change of interaction energy when polymer and solvent mix together. 
The χ parameters of hydrogels can be calculated using Equation 4 (Çaykara, et al. 2006).  
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In order to calculate ϕ using Equation 3, the following parameters were used: mass of hydrogel 
before (mb), the mass of the hydrogel after swelling (ma), the density of the hydrogel (dp) and the 
density of the solvent (ds). The density of the hydrogel films was calculated using Equation 5. 
 
XS
wd p
×
=            (5) 
Where X is the average thickness of the film, S is the cross-sectional area and w weight of the film 
(Raj Singh, et al. 2009). 
The crosslink density (Ve) was determined using Equation 6. Ve represents the number of elastically 
effective chains, totally induced in a perfect network, per unit volume (Bajpai and Singh 2006; Raj 
Singh, et al. 2009). Where NA is Avagadro’s number (6.023 × 10
23
 mole
−1
)  
c
Ap
e M
Nd
V
×
=            (6) 
Attenuated total reflectance (ATR)-Fourier transform infrared (FTIR) spectroscopy was used to 
evaluate the esterification reaction between GAN and T85. The IR spectra were recorded at room 
temperature using a FTIR Accutrac FT/IR-4100 Series (Jasco, Essex, UK) equipped with MIRacle™ 
software between 4000–600 cm
−1
 with a resolution of 4.0 cm
−1
. The obtained spectra were the result 
of averaging 64 scans. 
Samples were analyzed at room temperature using a MiniFlex II desktop powder X-ray 
diffractometer (Rigaku Corporation, Kent, England) equipped with Cu Kβ radiation, at a voltage of 30 
kV and a current of 15 mA. All samples were scanned within the angular range of 1.5–50° 2θ in 
continuous mode. 
The morphology of the hydrogels was evaluated by using electronic and optical microscopy. A 
Hitachi TM3030 benchtop scanning electron microscope (SEM) (Tokyo, Japan) was used. Samples 
were analysed after swelling in water and after being freeze dried. Samples were measured directly 
without any sample preparation. The morphology of the hydrogels was evaluated using a Leica EZ4 D 
digital microscope (Leica, Wetzlar, Germany). Hydrogels were observed in the swollen state and in 
the dry state after freeze drying the swollen hydrogels  
 
2.5. Curcumin loading and release 
All the hydrogels were loaded with CUR by immersing the dry film in 1 mL of a 20mg/mL solution of 
CUR in acetone. The film was left inside the solution for 24 hours. After the loading process films 
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were removed, dried with filter paper to eliminate the superficial excess of CUR solution. In order to 
evaluate the loading capacity of the hydrogels, the loaded films were placed in 20 mL of ethanol 
over a 24 hour timeframe until all the CUR was released. The concentration of CUR in the ethanol 
was evaluated using a UV-visible plate reader (PowerWave XS Microplate Spectrophotometer, Bio-
Tek, Winooski, USA) at a wavelength of 425 nm. The experiment was done in triplicate. 
CUR loaded films were placed cut in 4 fragments and a one of the fragments was placed in a tube 
containing 10 mL of PBS (pH 7.3) with 10% of Tween 80 to maintain sink conditions. The release 
media contains 1 mg/mL of ascorbic acid to prevent CUR oxidation. All the tubes were placed in a 
shaking incubator (40 rpm and 37°C). For comparison purposes, the dissolution of pure CUR powder 
in the release media was evaluated. CUR powder (ca. 1.2 mg) were placed in a tube containing 12 mL 
of PBS (pH 7.3) with 10% of Tween 80 and 1mg/mL of ascorbic acid. 
Ascorbic acid was required to obtain consistent results for the CUR quantification method 
development. Without this compound the calibration curves presented high variability. This can be 
observed in Figures S1A and S1B (supporting information). Additionally, the stability of CUR in the 
release medium with and without ascorbic acid was studied. The results (see supporting information 
Figure S1C) showed that CUR was stable in both media for at least around 24 h. However, the CUR 
concentration obtained in the medium containing ascorbic acid were less variable. The combination 
of Tween 80 and ascorbic acid provided high stability to CUR in solution. This crucial as it has been 
reported previously that CUR is highly unstable in aqueous environment (Kharat, et al. 2017). 
At certain times the release medium was replaced with fresh one and the concentration of CUR was 
evaluated using a UV-visible plate reader at a wavelength of 425 nm. For CUR powder control, at 
defined times a samples (0.02-0.05 mL) were collected to evaluate the concentration of CUR 
dissolved and they were replaced by fresh medium. 
Films loaded with CUR were analysed using infrared spectroscopy (see above) and a TA Instruments 
DSC Q100 differential scanning calorimeter (DSC Q100). Samples were analysed from 0 to 200°C at a 
heating speed of 10°C/min. 
 
2.6. Analysis of release data. 
Different parameters were calculated with the CUR release data obtained from the hydrogels. The 
mean dissolution time (MDT) can be calculated using Equation 7 (Costa, et al. 2001). 
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where j is the sample number, n is the number of dissolution sample times, jtˆ  is the time at the 
midpoint between tj and tj-1 and ΔMj is the additional amount of drug dissolved between tj and tj-1. 
The dissolution efficiency (DE) of a pharmaceutical dosage form is defined by the percentage of area 
under the dissolution curve up to a certain time t expressed as a percentage of the area of the 
rectangle described by 100% dissolution (y100) in the same time (Equation 8) (Costa, et al. 2001). It is 
important to notice that in this case the formulation is not dissolved as it is a hydrogel, however we 
have used this parameter in order to compare CUR release from all the different types of hydrogels. 
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           (8) 
In order to compare different release curves, the difference (f1) and similarity factor (f2) were 
calculated (Costa, et al. 2001). The difference factor (f1) (Equation 9) calculates the percent (%) 
difference between the two curves at each time point and is a measurement of the relative error 
between the two curves: where n is the number of time points, R is the dissolution value of the 
reference t (prechange) batch at time t, and T is the dissolution value of the test (postchange) batch 
at time t. 
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The similarity factor (f2) (Equation 10) is a logarithmic transformation of the sum-squared error of 
differences between the test Tj and reference products Rj over all time points, n (Costa, et al. 2001). 
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The data obtained from the in vitro release experiments were fitted to different mathematical 
models of drug release. The models used for this study were the Korsmeyer-Peppas model (Equation 
11) and the Higuchi model (Equation 12). 
The Korsmeyer-Peppas model exponentially relates drug release with the elapsed time (Costa, et al. 
2001; Ritger and Peppas 1987). 
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n
· tk KPtM
M
=
∞
           (11) 
where Mt/M∞ is the drug release fraction at time t, kKP is a constant incorporating the structural and 
geometric characteristics of the matrix tablets, and n is the release exponent indicative of the drug 
release mechanism. The value of n indicates the mechanism of the release.27 If the value is around 
0.5 (the exact value depends of the geometry) the mechanism is Case I (Fickian) diffusion and a value 
between 0.5 and 0.89 indicates anomalous (non-Fickian) diffusion. Values of n equal to 0.89 indicate 
Case II transport. 
If the obtained release mechanism is mainly a Fickian diffusion, the Higuchi model was used (Costa, 
et al. 2001) (Equation 12). In this case Mt/M∞ is the drug release fraction at time t and kH is the 
Higuchi constant. In the original Higuchi equation, the Mt (amount of drug released at time t) term is 
found instead of Mt/M∞. 
0.5
· tk HtM
M
=
∞
           (12) 
The zero-order kinetics equation was also used in order to evaluate the type of release mechanism. 
This model is used for systems where the matrix releases the same amount of drug by unit of time 
(Costa, et al. 2001). This model relates the amount of drug dissolved with time. However, we have 
used a modified zero-order equation, where we have replaced the amount or drug released term by 
Mt/M∞ (Equation 13).  
· tk ZO=
∞
M
M t             (13) 
In this case Mt/M∞ is the drug release fraction at time t and kZO is the Zero-Order constant. 
 
2.7. In vitro mucoadhesion study 
The mucoadhesive properties of the hydrogels were evaluated using a TA-XT2 Texture Analyser 
(Stable Micro Systems, Surrey, UK). Mucin discs were manufactured by compression of mucin (500 
mg) using a ring press with a 13 mm die and a compression force of 10 tonnes, applied for 30 s. 
These were attached to an aluminium block using double sided adhesive tape. Hydrogel films were 
attached to the equipment probe with double side adhesive tape. Before starting the test, around 
200 µL of a mucin solution was applied to the surface of the mucin disc and after 30 s it was blotted 
with tissue paper. A defined force of 0.1 N was applied for 30 s to ensure intimate contact between 
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the mucin disc and the sample. The probe was then moved vertically upwards at a constant speed of 
1.0 mm s−1 and the force required to detach the mucin disc from the surface of each formulation was 
determined from the resultant force-time plot. All measurements were performed, at least, in 
quadruplicate. 
 
2.8. Release of CUR from hydrogel microparticles 
Hydrogel microparticles (MPs) were prepared by milling 5 T85 hydrogels in a coffee grinder. The 
obtained powder was sieved and the fraction with sizes ranging between 45 and 90 µm were 
collected. The morpohology of the particles was observed using SEM (Hitachi TM3030). 
The particles were loaded following the same protocol described for the loading of the hydrogels. 
Between 100 -200 mg of the particles were placed in 2mL of a CUR acetone solution (20 mg/mL). 
After 24 hours the particles were isolated by filtration and washed with acetone in order to remove 
the excess of CUR loaded. The CUR loading was evaluated by placing 2.5 mg of the particles in 2 mL 
of ethanol. After 24 hours, all the CUR contained in the particles was released and the concentration 
was evaluated as described before. 
The release kinetics of CUR loaded microparticles was evaluated simulating the gastrointestinal tract 
conditions. During the first two hours the release medium was HCl 0.12 M simulating gastric 
conditions. Subsequently the release medium was changed to PBS to simulate intestinal conditions. 
In all cases the release media contained ascorbic acid (1mg/mL) to prevent CUR degradation. At 
certain times the release media was replaced with fresh one and the amount of released CUR was 
evaluated by using UV-visible spectroscopy. 
For comparison purposes, the dissolution of pure CUR powder in the release media was evaluated. 
CUR powder (ca. 1 mg) were placed in a tube containing 20 mL of simulated gastric solution and 
simulated intestinal solution. At defined times a samples (0.02-0.05 mL) were collected to evaluate 
the concentration of CUR dissolved and they were replaced by fresh medium. 
 
2.9. Statistical Analysis 
Where appropriate, data was analyzed using a one-way ANOVA with post hoc comparisons 
performed using the Tukey–Kramer test. In all cases, p < 0.05 denoted significance. Statistical 
Package for the Social Sciences, SPSS 18.0 version 2.0 (SPSS, Inc., Chicago, IL, USA), was used for all 
analyses. 
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3. Results 
3.1 Hydrogel characterization 
GAN has been used in the past to prepare hydrogels through esterification reactions (Larrañeta, et 
al. 2015; Moreno, et al. 2014). T85 is an ideal candidate to introduce hydrophobic domains in the 
hydrogel structure. This surfactant present a complex structure containing oleic acid chains and 
alcohol groups (Solak, et al. 2014). The alcohol groups can be used to crosslink GAN chains by 
reaction with the acid groups present in GAN molecules. 
Figure 1A shows the size distribution of T85 solutions in water. It can be seen that surfactant forms 
aggregates with different sizes ranging from 10 nm to 1 µm. The size distribution changes as a 
function of the concentration. These results showed the tendency of T85 to form aggregates in 
aqueous environments due to its amphiphilic nature. All the solutions presented a certain degree of 
turbidity confirming this tendency. Consequently, we decided that T85 was a good candidate to be 
incorporated within hydrogels to add hydrophobic domains to the structure. 
 
Figure 1B shows the swelling profiles in water of all synthesized hydrogels. As can be seen in Figure 
1B, hydrogels containing higher concentrations of T85 showed lower swelling capacities (p < 0.05). 
Higher concentrations of T85 in the materials yielded hydrogels with higher crosslinking degrees and 
consequently, lower swelling capacity. In order to compare GAN/T85 hydrogels with a similar 
hydrogel that does not contain hydrophobic domains, P2 hydrogel was used as control. This hydrogel 
has been used extensively in the past for drug delivery purposes (Donnelly, et al. 2012; Larrañeta, et 
al. 2015; Raj Singh, et al. 2009). This control hydrogel showed a similar swelling profile compared to 
T3. 
Table 2 shows the network parameters obtained for all the different hydrogels. The volume fraction 
of polymer in the swollen state (ϕ) represents the amount of liquid that can be absorbed by an 
hydrogel (Raj Singh, et al. 2009). As can be seen in Table 2, this parameter decreased when the 
concentration of T85 in the hydrogels increased. Furthermore, the average molecular weights 
between crosslinks, Mc (Equi), increases with the concentration of T85 in the hydrogel. 
The polymer–water interaction parameter (χ) is proportional to the crosslink density. The higher the 
value of χ, the weaker is the interaction between the polymer and water. Therefore, increasing the 
crosslinking degree increased the interaction between the polymeric system and water. 
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Furthermore, Ve is another good indicator of the crosslinking density. It represents the number of 
elastically effective chains, totally induced in a perfect network, per unit volume (Bajpai and Singh 
2006; Raj Singh, et al. 2009). Consequently, hydrogels with higher crosslinking densities presented 
higher Ve. The calculated Ve values are consistent with the results obtained in the swelling studies: 
hydrogels with higher amount of T85 showed higher crosslinking degrees. Finally, it can be seen that 
all the calculated network parameters for P2 and T3 are similar. This is consistent with the results 
described previously. 
The presence of T85 within the hydrogel structure influenced the swelling of the material when 
using alternative solvents. The study of the absorption of organic solvents by the hydrogels is a good 
way to ascertain the hydrophobicity of the materials. Figure 1C shows the maximum swelling of the 
hydrogels in water, acetone and ethanol. Additionally, Figure 1D shows the maximum swelling of the 
hydrogels as a function of the relative polarity of the solvent. P2 hydrogels showed lower swelling 
capacity in acetone than the GAN/T85 hydrogels (p < 0.05) (Figure 1C). However, it showed similar 
ethanol uptake to T5 (p > 0.05). The solvent uptake in this case is proportional to the relative polarity 
of the solvent (Figure 1D) showing that the highest swelling was obtained in water and the lowest in 
acetone. On the other hand, T85 containing hydrogels presented a different behaviour (Figure 1C). 
T2 hydrogels showed a higher swelling capability in water than in ethanol (p < 0.05). On the other 
hand, hydrogels containing higher concentrations of T85 showed comparable swelling capacity in 
ethanol and water (p > 0.05). The higher ethanol uptake for hydrogels containing T85 can be 
explained by the presence of oleic acid chains in the structure of the surfactant. This fatty acid 
presents unlimited solubility in ethanol at ambient temperature (Hoerr and Harwood 1952) and 
consequently the interactions of T85 with ethanol are energetically favourable. Besides, the swelling 
in ethanol follows the same trend obtained in water: higher swelling degrees were obtained for 
hydrogels with lower T85 concentrations. This indicates that the affinity of T85 and ethanol is not 
the only limiting factor as the crosslinking degree of the hydrogel plays a more important role. 
The swelling capacity of these materials in acetone was lower than the one obtained in ethanol (p < 
0.05) with the exception of T5 (p = 0.999). Interestingly, in this case the higher swelling in acetone 
was obtained for T5. Despite having higher crosslinking degrees, the presence of higher amounts of 
T85 in its structure allows a higher acetone uptake. This can be explained by the solubility of oleic 
acid in acetone. Hoerr et al. showed that the solubility of this fatty acid in acetone was unlimited at 
ambient temperature (Hoerr and Harwood 1952). Consequently, there are favourable interactions 
between the solvent and the hydrophobic moieties of T85. This trend can be seen in Figure 1D as it 
demonstrates that hydrogels containing higher quantities of T85 showed better absorption of 
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solvents with lower polarity. The ability to uptake organic solvents is really useful for drug loading 
applications, as it is a good way to load hydrophobic drugs inside the hydrogel. 
Figure 2 shows SEM images of the hydrogels in the swollen state and after being freeze dried. It can 
be seen that all the materials showed a compact structure when swollen. It is important to note that 
the images were captured using an environmental SEM and the samples should be placed in a 
vacuum chamber. Consequently, it is quite likely that the swollen hydrogels lose water during the 
process. The presence of pores in T5 hydrogels can be observed. These pores are generated by 
trapped air bubbles. Due to the viscosity of the aqueous mixtures used to prepare T5 films, small air 
bubbles were trapped in the structure. 
After the freeze drying process, the structure of the hydrogels showed high porosity. The size of the 
pores can be related with the swelling capacity of the hydrogels. The pores were smaller in T5 while 
higher pore sizes were evident in T3 and T2. Interestingly, P2 hydrogels showed a smaller pore size 
distribution than T3 hydrogels. Both hydrogels showed similar water uptake capabilities but their 
internal structure after swelling showed some differences. This can be explained by the presence of 
the surfactant in T3 generating hydrophobic domains inside the hydrogel. 
Hydrogels were analysed by using FTIR spectroscopy. Figure 3A shows the spectra of P2 and T3 
before and after the crosslinking reaction. The main difference between the crosslinked and non-
cross-linked (NC) materials can be found in the carbonyl region. After the crosslinking process 
different reactions took place: esterification between T85/PEG and GAN and anhydride formation 
between two GAN acid groups (Larrañeta, et al. 2015). The esterification can be ascertained by the 
shift of the carbonyl peak at around 1700 cm
-1
. The infrared carbonyl peaks for carboxylic acids and 
esters are overlapping (Sclavons, et al. 2000). The observed peak shift suggests the presence of a 
new ester peak overlapping with the previous acid peak (Sclavons, et al. 2000). Additionally, a new 
peak appears at around 1780 cm
-1
, due to the formation of anhydride groups between two acid 
groups in the GAN molecule (Larrañeta, et al. 2015; Sclavons, et al. 2000). The anhydride formation 
can be ascertained by the presence of two new peaks between 1750 and 2000 cm
-1
. Figure 3B shows 
the FTIR spectra of all the crosslinked hydrogels. It is important to note that the peak attributed to 
ester carbonyl presented higher relative intensity in T5 hydrogels and the lower in T2 hydrogels. This 
is consistent with the swelling results suggesting that the crosslinking degree is proportional to the 
T85 concentration. The similar peak shape for P2 and T3 hydrogels reinforces the results obtained in 
the swelling studies. 
The presence of amphiphilic molecules within the hydrogel structure will induce the formation of 
hydrophobic domains. X ray diffraction (XRD) was used to evaluate the internal structure of the 
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hydrogels. Figure 4A shows the XRD pattern obtained for all the synthesized hydrogels. The 
diffraction patter of all the hydrogels, including P2, showed a broad peak suggesting an amorphous 
structure. However, the peak is sharper for the hydrogels prepared using higher concentrations of 
T85. This suggest an increase in the internal order. The area and the full width at half maximum 
(FWHM) values of the diffraction peaks are related to the crystallinity of the material (Parthiban, et 
al. 2006). Consequently, the FWHM of these peaks was measured (Figure 4B). The obtained values 
can be correlated with the T85/GAN ratios suggesting that hydrogels containing higher amounts of 
T85 presented lower FWHM, and consequently a higher degree of internal order. This results 
suggest that the presence of T85 in the structure contributes to the internal order or the hydrogels. 
Consequently, this internal order should be a result of the internal hydrophobic domains generated 
by the presence of T85. 
Figure 5 shows images of the hydrogels before and after hydration. It can be seen that the hydrogels 
presented certain degree of turbidity when swollen. The materials showed a similar behaviour than 
the T85 solutions. The results suggest that T85 is forming hydrophobic domains inside the hydrogel 
structure. On the other hand, P2 hydrogels did not show any turbidity when swollen as this type of 
hydrogels does not present hydrophobic domains (data not shown). 
 
3.2. Curcumin release studies. 
CUR is an hydrophobic polyphenol with hypoglycemic, antioxidant, wound-healing, anti-
inflammatory and antimicrobial activities (Aggarwal and Sung 2009). Therefore, it is an ideal 
candidate as a model compound to study the loading and release capabilities of the synthesized 
hydrogels. Figure 6A shows the chemical structure of CUR. 
Table 3 shows the CUR loading capacity of the hydrogels. It is important to note that hydrogels 
containing higher amounts of T85 presented higher loading capacities. Hydrogels were loaded by 
placing them in a CUR acetone solution. The loading results can be correlated with the swelling of 
the hydrogels in acetone and with the %T85 in the hydrogel (see supporting information Figure S2). 
Consequently, the addition of hydrophobic moieties to the hydrogel improves significantly 
hydrophobic drug loading. Moreover, it is important to note that there was no significant difference 
between T3 and T5 CUR loading (p = 0.958). This suggest that the system reached a maximum CUR 
uptake as increasing the concentration of T85 in these hydrogels did not translated into a higher 
drug loading.  
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FTIR and DSC were used to analyse CUR containing hydrogels. Figure 6B shows the FTIR spectra of 
pure CUR and the hydrogels before and after being loaded with this molecule. The result showed 
that the peak attributed to the CUR carbonyl group (1500 cm-1) (Mohan, et al. 2012) can be seen in 
all the loaded hydrogels. A peak shift can be observed suggesting that CUR molecules interact with 
the hydrogel structure. The shift is more noticeable for T85 containing hydrogels. Similar behaviour 
has been reported by Mohan et al. for the complexation of CUR with cyclodextrins (Mohan, et al. 
2012).  
Figure 6C shows the DSC curves obtained for CUR and the loaded hydrogels. In all cases, the CUR 
melting peak (ca. 180 ºC) cannot be seen in the DSC curves of the hydrogels. Similar results were 
obtained for CUR/cyclodextrin complexes (Mohan, et al. 2012). This suggest that CUR molecules are 
dispersed in the hydrogel matrix. Therefore, the results obtained from FTIR and DSC suggest that the 
drug is interacting with the polymeric chains of the hydrogel. 
The release of CUR from the synthesized hydrogels can be seen in Figure 7A. It is important to note 
that the mass of the hydrogels used in these experiments was slightly different for every type of 
hydrogel as a piece of film was divided in 4 (see material and methods section). Consequently, and in 
order to compare the release profiles properly, Figure 7C was included showing the % of the loaded 
CUR released as a function of time. P2 hydrogels showed the fastest CUR release (Figure 7B). This 
type of hydrogels released all the CUR cargo within 1 day. On the other hand, T85 containing 
hydrogels showed a prolonged CUR release over a period of 30 days. T2 and T3 showed similar 
release profiles. On the other hand, T5 hydrogels presented a more sustained release profile. The 
results demonstrate that the presence of T85 in the hydrogels allows sustained releases of CUR. 
Figure 7D shows the dissolution profile of CUR in the release medium. For this experiment the 
selected amount of CUR was adapted to be similar to the amount present inside the hydrogels. As 
the experiment was performed under sink conditions after 3-4 hours all the CUR powder was 
dissolved. Consequently, we can consider that hydrogels are responsible for the sustained release 
profiles. 
In order to compare the obtained release profiles, DE, MDT and f1 and f2 were calculated (Table 4). 
CUR released from P2 hydrogels showed the highest DE values. Hydrogels containing T85 showed a 
decrease in the DE proportional to the T85 content. This indicates that the presence of more 
hydrophobic domains inside the hydrogels slows down CUR release process. The MDT results 
showed that P2 provided the quickest release of 50% of the CUR cargo. T2 and T3 showed similar 
MDT values. However, according to these results, T2 showed a slightly slower release. Finally, T5 
showed the highest MDT values. 
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In order to compare all the release curves f1 and f2 factors were calculated (Table 4). When 
comparing two release curves, if the calculated f1 values are lower than 15 and the values of f2 are 
higher than 50 both curves can be considered equivalent. According to this, T2 and T3 showed 
equivalent CUR release profiles. However, in the next paragraphs it will be discussed that despite 
having equivalent CUR release capacity, the release mechanism is slightly different. 
Table 5 shows the results obtained after fitting the release data to the Korsmeyer-Peppas and 
Higuchi model. The Korsmeyer-Peppas model was used to calculate the main mechanism of drug 
release. The obtained “n” values ranged between 0.45 and 0.55, suggesting that the CUR release 
from the hydrogels is governed by Fickian diffusion (Larrañeta E, et al. 2014; Ritger and Peppas 
1987). 
Higuchi model was used as it is a model designed for drug delivery systems with release governed by 
pure Fickian diffusion. As can be seen in Table 5, the R
2
 values indicating good fitting to the Higuchi 
model. These results are consistent with the results obtained before, suggesting that the main 
release mechanism of CUR from the all the hydrogels is Fickian diffusion. 
It is important to note that despite of presenting similar release profiles when calculating f1 and f2 
factors, T2 shows a different release profile than T3. T3 showed a good fitting to the Higuchi model 
however T2 curve shows a biphasic release pattern as 5 days after starting the release process the 
curves showed a linear release (Zero Order kinetic). This process continued between the day 5 and 
the day 24. Consequently, the Korsmeyer-Peppas and Higuchi models were applied again to the T2 
release data obtained within the first 3 days of release instead of the previous first 7 days (≤ 60% 
release) (Table 5). The obtained results showed better fitting to both equations, suggesting that 
during the first 3 days the release process was governed by a diffusion mechanism. Moreover, a Zero 
Order model was applied to the next section of the release curve (5-24 days) showing good 
correlation with the model (Table 5). After a few days from the beginning of the release experiment 
some opaque domains were formed within T2 structure that disappeared over time. This 
observation suggests that CUR crystallization within the hydrogel structure. The crystallization of 
CUR in T2 can be explained by the lower amount of T85 in these hydrogels to stabilize CUR 
preventing crystal growth when compared with T2 and T3. These factor can explain the difference in 
the release mechanism for T2.  
 
3.3. Tween 85-based hydrogels as oral drug delivery systems. 
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GAN polymers present a large number of acid groups that can form hydrogen bonds. Therefore, this 
type of polymers has been used extensively to prepare mucoadhesive systems for oral drug delivery 
(Agüeros, et al. 2011; Arbós, et al. 2002; Ojer, et al. 2013). Mucoadhesive drug delivery systems 
interact with the mucus layer of the gastrointestinal tract, increasing the residence time of the 
dosage form at the site of absorption (Boddupalli, et al. 2010). Additionally,  due to the presence of 
the acid groups, GAN provides pH dependant drug delivery showing different release rates under 
gastric and intestinal conditions (Agüeros, et al. 2009). 
Due to the presence of GAN in the hydrogels, the materials described in this work have the potential 
to be used as oral mucoadhesive drug delivery systems. Figure 8 shows the mucoadhesion test of 
the all the hydrogels studied in the present work. Despite the different adhesion force obtained for 
P2, T2 and T3 hydrogels, there is no significant differences in their mucoadhesivity (p > 0.05). 
However, T5 showed a lower adhesion force than T3 (p = 0.012). T5 has a higher crosslinking degree 
than T3, and consequently, it has lower free acid groups to take part in the adhesion process. The 
obtained results suggest that the adhesion forces are higher than the ones obtained by Calo et al. for 
a similar type of hydrogels (Calo, et al. 2016b).  
All the hydrogels showed good mucoadhesivity but T2 and T3 were selected for further studies due 
to their drug delivery capabilities. T5 was discarded as the drug release from this type of hydrogels 
was considered too slow for oral drug delivery systems. The swelling behaviour of T2 and T3 at 
different pHs, simulating gastric and intestinal conditions, were tested (Figure 8 B). It can be seen 
that, due to the presence of multiple acid groups in the hydrogel, both hydrogels showed lower 
swelling at lower acidic pHs. Higher pH causes dissociation of COOH groups of GAN, preventing 
intermolecular –COOH⋯HO– bonds  and, consequently, yielding higher swelling degrees (Calo, et al. 
2016a). T2 hydrogels showed a larger swelling difference between the tested pHs. Consequently, 
this type of hydrogels was selected for further studies. 
The results presented in Figure 7 suggested that the release from T85 based hydrogels is slow. 
Consequently, we decided to reduce the size of the hydrogels to accelerate the drug release process. 
MPs of T2 were obtained by milling hydrogel films. Moreover, a powder formulation is a better 
alternative for oral drug delivery than hydrogel films, as the MPs powder can be easily encapsulated 
or compressed to obtain tablets. The MPs presented sizes ranging between 45 and 90 µm. Figure 9A 
shows SEM images of the obtained particles. The particles were loaded with CUR, obtaining a 
loading of 41 ± 7 mg CUR/g hydrogel.  
Figure 9B shows the release of CUR from the MPs in two different release media: simulating gastric 
(HCl) and intestinal conditions (PBS). The dissolution kinetics of CUR powder was studied in both 
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simulated gastric and intestinal conditions (Figure 9C). A CUR burst release from the MPs can be 
observed during the first hour. During this time around 50% of the loaded CUR was released. After 
this initial burst, CUR is released in a sustained way during the next 6 hours. On the other hand, 
during the first hour around 60-70% of the pure CUR was dissolved in simulated intestinal and gastric 
conditions. Subsequently, all the free CUR was dissolved during the next 2 hours in both media.  
It is important to note that MPs provided between 3 and 4 hours of sustained release when 
compared to the dissolution of the free drug. This behaviour is consistent with the obtained CUR 
release from the hydrogels (Figure 7). The initial burst release can be due to the presence of CUR 
inside the MPs that is not interacting with the hydrophobic T85 domains. Nevertheless, it can be 
seen that, despite the pH-depending swelling of the hydrogels, the release does not show a biphasic 
pattern. This indicates that the release mechanism is governed by the interactions of the 
hydrophobic drug with the hydrogel network containing hydrophobic moieties. In addition, it can be 
seen that the profile is heavily influenced by the particle size as the MPs are able to release all the 
CUR cargo in 7 hours. 
The results from this experiment showed that the hydrogel particle size strongly influences the 
release kinetics. Hydrogel films were able to provide up to 30 days of release while MPs were able to 
provide only 7 hours of release.  
 
4. Discussion  
Drug delivery systems based on hydrogels, have been limited to carrying hydrophilic drugs rather 
than hydrophobic drugs (Hoare and Kohane 2008; McKenzie, et al. 2015). The main reason for this is 
the limited quantity/homogeneity of loaded hydrophobic drugs in hydrogel matrices (McKenzie, et 
al. 2015). During the past decade, numerous research has been published describing strategies to 
improve hydrophobic drug loading/release capabilities of hydrogels (Gu, et al. 2016; McKenzie, et al. 
2015). This is a key challenge as over 40% of the marketed drugs and about 60% of the therapeutic 
compounds at the research and development stage are hydrophobic compounds (Fahr and Liu 2007; 
Gu, et al. 2016). Consequently, there is a need for the development of new types of hydrogels for 
hydrophobic drug delivery. 
Combined strategies have been used to improve the compatibility of hydrogel materials with 
hydrophobic drugs, including the insertion of cyclodextrins, hydrophobic moieties, nanoparticles or 
micelles within the hydrogel structure (Concheiro and Alvarez-Lorenzo 2013; Gu, et al. 2016; 
Jalalvandi, et al. 2017; Machín, et al. 2013; McKenzie, et al. 2015). These systems provided 
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controlled drug release over different periods of time, ranging from a few hours to several days (Gu, 
et al. 2016). The type of application will be dependent on the type of hydrogel used and the drug 
release process.  
In the present work, we described the synthesis of hydrogels containing T85 for hydrophobic drug 
delivery. Polysorbates such as T85 and GAN have been used extensively to prepare pharmaceutical 
formulations (Agüeros, et al. 2011; Kaur and Mehta 2017; Larrañeta, et al. 2015). These compounds 
have also been shown to be non-toxic (Ojer, et al. 2013; Sigward, et al. 2013). Therefore, they are 
good candidates to be used in this study. 
Hydrogels were obtained through an esterification reaction carried out in solid state. The synthetic 
does not require the use of any type of organic solvent and the only by-product generated after the 
esterification reaction is water. Synthetic processes that do not require the use of organic solvents 
and reagents that can present toxicity problems are ideal for biological applications. Consequently, 
the described synthetic process can be considered safe and environmental-friendly. FTIR 
measurements (Figure 3) and the swelling of the resulting hydrogels (Figure 1) confirmed the 
crosslinking reaction. A similar procedure has been used before to prepare GAN hydrogels, however 
these materials were used mainly for the delivery of hydrophilic drugs as the selected crosslinkers 
were PEG or poly(vinyl alcohol) (Calo, et al. 2016b; Raj Singh, et al. 2010). 
One of the main limitations of hydrogels for pharmaceutical applications is their inability to control 
the drug release over longer periods of time (Hoare and Kohane 2008). The high water content and 
large pore sizes of these materials often result in relatively rapid drug release. GAN/T85 hydrogels 
do not present this limitation due to the presence of hydrophobic moieties inside the hydrogel. CUR 
was selected as model hydrophobic drug to evaluate the drug loading/release capabilities of the 
hydrogels. It can be seen that the presence of hydrophobic moieties within the hydrogels improved 
significantly the loading of the molecule inside the materials. Furthermore, the presence of T85 in 
the hydrogels provided sustained release up to 30 days. 
Hydrogel-based systems have been used before as platforms to delivery CUR (Alibolandi, et al. 2017; 
Gong, et al. 2013; Li, et al. 2012; Sun, et al. 2014). All these systems were designed as hydrogels 
containing CUR nanoparticles/nanosuspensions. For this purpose, hydrogels? should be prepared 
around the preformed nanosuspensions. These systems were able to sustain CUR release over a 
period ranging between a few hours to 15 days. As the system described in the present paper 
already contains the hydrophobic domains inside the hydrogels, there is no need to include any type 
of CUR containing nanocarrier. These hydrogels also provided sustained release process over longer 
periods of time.  
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The hydrogels described in this work demonstrate potential to be used as drug eluting implants, as 
they allow sustained releases over long periods of time. Examples of hydrogels used for this aim can 
be found in the literature (Gu, et al. 2015; Pitarresi, et al. 2013). The hydrogels can be implanted 
subcutaneously, using a simple surgical procedure, providing a prolonged release of the loaded drug. 
GAN/T85 hydrogels showed promising properties to be used as drug eluting implants. However, the 
non-degradable nature of the polymers forming the hydrogel need to be considered. Accordingly, 
this type of material should be surgically implanted and removed after exhausting its drug cargo. 
The proposed materials have potential for other drug delivery applications, such as oral drug 
delivery systems. Due to the presence of GAN in the structure, the prepared hydrogels showed good 
mucoadhesive properties and pH-dependant swelling (Figure 8). Hydrogel MPs containing CUR were 
used as drug delivery systems. The results showed that CUR release was not influenced by the pH 
(Figure 9). In addition, the size reduction allowed to accelerate drug release. The MPs were able to 
release their cargos in 7 hours. The release profiles obtained for the MPs are more suitable for oral 
drug delivery applications than the extended release profiles obtained for the hydrogels (Figure 7). 
Interestingly, the release from the hydrogel MPs is not as sustained as the one obtained for the 
hydrogel films and it is close to the dissolution profile of the free drug. Consequently, the 
dimensions of the hydrogels should be chosen carefully as a function of the application. However, 
one of the advantages of the hydrogel MPs is their mucoadhesive properties that will expand the 
residence time of the system in the gastrointestinal tract. 
CUR loaded MPs presented a burst release during the first hour. Further studies should evaluate 
alternative strategies to reduce this initial release. If the system is designed to be adhered to the 
intestinal mucosa and release its cargo there, the MPs should be encapsulated in a gastro-resistant 
capsule. An alternative solution will be to increase the particle size of the hydrogels or to use 
hydrogel films. Consequently, further studies should be performed to evaluate the influence of the 
particle size in the loading/release of hydrophobic compounds from this type of hydrogels. 
 
 
5. Conclusions 
The present paper describes the synthesis of hydrogels made of Gantrez and Tween 85. The 
resulting hydrogel materials contained hydrophobic moieties, improving the compatibility of the 
materials with hydrophobic compounds. The synthetic process is simple and, as it does not require 
any toxic or organic solvents. Consequently, it can be considering safe and environmental-friendly. 
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The obtained hydrogels were able to be successfully loaded with CUR, a hydrophobic model drug 
molecule, and to sustain the release of this compound over 30 days. Consequently, the material 
showed potential to be used for long term drug release applications, such as implants. Additionally, 
this type of hydrogels was tested for oral drug delivery applications, as the synthesized materials 
were mucoadhesive. Hydrogel MPs were prepared and tested for CUR release under simulated 
gastric and intestinal conditions. The results suggested that this type of material can be used for oral 
drug delivery but further work is required to optimize it. 
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Figure 1. Size distribution obtained for different aqueous solutions containing different 
concentrations of Tween 85 (A). Swelling profiles of the synthesized hydrogels (B). Maximum 
swelling of the synthesized hydrogels in different organic solvents (C). Maximum swelling of the 
synthesized hydrogels as a function of the relative polarity of the solvent (D). 
 
Figure 2. SEM images of swollen and freeze-dried hydrogels. 
 
Figure 3. FTIR spectra of crosslinked and non-crosslinked (NC) P2 and T3 (A). FTIR spectra of the P2, 
T2, T3 and T5 after the crosslinking process. 
 
Figure 4. XRD patterns of P2, T2, T3 and T5 (A). The full width at half maximum (FWHM) of the XRD 
peak of P2, T2, T3 and T5 hydrogels (B). 
 
Figure 5. Images of T85/GAN hydrogels in their dry and swollen state. 
 
Figure 6. Chemical structure of CUR (A). FTIR spectra of CUR and the hydrogels before and after 
being loaded with CUR (B). DSC of CUR and CUR loaded hydrogels. Exo Up. 
 
Figure 7. CUR cumulative release from different hydrogels. Graphs shows the amount (A and B) and 
the percentage (C) of CUR released as a function of time. CUR released from P2 hydrogels (B). 
Percentage of CUR powder dissolved as a function of time (D). 
 
Figure 8. Mucoadhesion force for the hydrogels (A). Swelling profiles of T2 and T3 as at pH 7.3 and 
pH 1.2. 
 
Figure 9. SEM images of T2 MPs (A). CUR release profile from T2 MPs in simulated gastric (HCl) and 
intestinal media (PBS) (B). Percentage of CUR powder dissolved in PBS as a function of time (C). 
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Table 1. Composition of the aqueous blends used to prepare GAN/T85 
Hydrogel 
Initial Mixture Composition 
T85/GAN 
GAN (%) (w/w) T85 (%) (w/w) PEG (%) (w/w) 
P2 20.0 - 7.5 27/73 
T2 20.0 5.0 - 20/80 
T3 20.0 10.0 - 33/67 
T5 20.0 20.0 - 50/50 
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Table 2. Network parameters obtained for the hydrogels 
Hydrogel ϕ Mc (Equi) (kDa) χ Ve x 10
-19 
P2 0.26 9.40 0.59 7.44 
T2 0.14 101.58 0.55 0.64 
T3 0.25 10.16 0.58 6.20 
T5 0.48 0.58 0.66 94.84 
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Table 3. CUR loading obtained for all the hydrogels. 
Hydrogel CUR loading (mg/g) 
P2 3.5 ± 0.1 
T2 26.6 ± 0.5 
T3 36.0 ± 0.3 
T5 35.7 ± 1.4 
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Table 4. Values of dissolution efficiency (DE), mean dissolution Time (MDT), difference (f1) and 
similarity factors (f2) obtained for the release curves of the hydrogels. 
Hydrogel DE (%) MDT (days) f1 f2 
P2 89.35 0.21 > 15 vs. all hydrogels < 50 vs. all  hydrogels 
T2 73.23 8.03 5.4 vs. T3 
> 15 vs the other hydrogels 
56.1 vs. T3 
< 50 vs the other hydrogels 
T3 70.17 7.75 5.4 vs. T2 
> 15 vs. the other hydrogels 
56.1 vs. T2 
< 50 vs the other hydrogels 
T5 52.53 9.40 > 15 vs. all hydrogels < 50 vs. all  hydrogels 
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Table 5. Results of fitting the release of CUR from different hydrogels to Korsmeyer-Peppas and 
Higuchi models. 
Hydrogel 
Range
1
 
(days) 
Korsmeyer-Peppas Model Higuchi Model 
Range
2
 
(days) 
Zero Order Model 
kKP 
(days
-n
) 
n R2 
kH 
(days
-1/2
) 
R2 
kZO ∙ 10
2
 
(days
-1
) 
R2 
P2 0-2 1.49 ± 0.05 0.45  ± 0.02 0.999 1.64 ± 0.02 0.998 - - - 
T2 0-7 0.26 ± 0.01 0.43 ± 0.02 0.991 0.24 ± 0.01 0.983 - - - 
T2
3
 0-3 0.27 ± 0.01 0.50 ± 0.02 0.997 0.27 ± 0.01 0.997 5-24 2.25 ± 0.01 0.999 
T3 0-7 0.21 ± 0.01 0.52 ± 0.01 0.999 0.22 ± 0.01 0.999 - - - 
T5 0-17 0.16 ± 0.01 0.45 ± 0.01 0.999 0.15 ± 0.01 0.996 - - - 
1 Range: the release data within this range was used to apply the Korsmeyer-Peppas and Higuchi 
models ( ≤ 60% release). 
2
 Range: the release data within this range was used to apply the Zero Order Model 
3 In this case T2 the release from T2 was separated in two sections to apply different release models: 
Korsmeyer-Peppas and Higuchi models for the first stage of the release (0-3 days) and Zero Order 
model for the last stage (5-24 days) 
 
